Defunct Company
Total Trials
19
As Lead Sponsor
15
As Collaborator
4
Total Enrollment
4,670
NCT02889822
The Tolerability of Alprostadil Liposome for Injection in Healthy Adult Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 31, 2010
Completion: Dec 31, 2010
NCT03173599
The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
Start: Dec 31, 2010
Completion: Apr 30, 2011
NCT02622659
The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)
Phase: Phase 4
Start: Mar 31, 2012
Completion: Mar 31, 2014
NCT03180333
The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers
Completion: Aug 31, 2012
NCT02965859
The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Phase: Phase 2
Start: Dec 31, 2012
Completion: Not specified
NCT02654158
Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection
Phase: N/A
Start: Aug 31, 2013
Completion: May 31, 2017
NCT03080740
The Efficacy and Safety Study of Clindamycin Palmitate Hydrochloride Dispersible Tablet Treatment of Bacterial Vaginosis
Start: Jul 31, 2016
Completion: Dec 31, 2017
NCT02877173
A Safety/Efficacy Study of Alprostadil Liposomes for Injection to Treat Lower Extremity Arteriosclerosis Obliterans
Start: Aug 31, 2016
NCT04665362
IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC
Role: Collaborator
Start: Jan 25, 2021
Completion: Oct 30, 2022
NCT04964752
A Study of the Continuous Glucose Monitoring System for Home Use in Patients With Diabetes
Start: Jul 30, 2021
Completion: Apr 30, 2022
NCT05038150
Study of SGN1 in Patients With Advanced Solid Tumor
Phase: Phase 1/2
Start: Jan 16, 2023
Completion: Aug 31, 2028
NCT05103345
Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Start: Apr 19, 2023
Completion: Jun 30, 2028
NCT06603142
Phase II/III Study of AR882 Capsules Compared to Febuxostat Tablets in Patients with Primary Gout and Hyperuricemia
Phase: Phase 2/3
Start: Apr 22, 2024
Completion: Apr 30, 2026
NCT06368921
A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Start: Jun 19, 2024
Completion: Dec 31, 2025
NCT06046742
A Study of Intravenous M1-c6v1 for Locally Advanced or Metastatic Solid Tumors
Start: Jul 10, 2024
Completion: Dec 20, 2026
NCT06866977
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer
Start: Mar 12, 2025
NCT06758544
A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer
Start: Mar 17, 2025
Completion: Nov 30, 2026
NCT06826313
A Study of Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors
Start: Mar 19, 2025
Completion: Mar 1, 2027
NCT07093814
A Study of VRT106 for Injection in Patients With Recurrent/Progressive Glioblastoma
Start: Sep 2, 2025
Completion: Jun 30, 2029